Please assess the completion status of the following clinical trial:

Trial Title: REMOGEN® Omega Versus Cationorm® in the Treatment of Patients Suffering From Dry Eye

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* With at least a 3-month documented history of bilateral dry eye~* With a score of ocular surface staining with fluorescein (OSSF) ≥ 4 and ≤ 9 on the Oxford scale~* With at least one objective sign of tear deficiency~* With Ocular Surface Disease Index (OSDI) score of ≥ 18~Exclusion Criteria:~* Refractive surgery within 12 months prior to selection~* Any other ocular surgery or ocular trauma within 6 months prior to selection~* Systemic or local use of one of the following medications: glucocorticosteroids, cyclosporine A, antibiotics, NSAIDs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Remogen (Type: EXPERIMENTAL): None
- Cationorm (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).